Twin Lakes Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Twin Lakes Capital Management, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $14.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$14.7M
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 58,102 | $8.1M |
| INCYIncyte Corp. | 20,000 | $1.9M |
| JNJJOHNSON & JOHNSON | 7,048 | $1.7M |
| ABTABBOTT LABORATORIES | 6,259 | $643K |
| NVSNovartis AG | 3,830 | $585K |
| PFEPFIZER INC | 16,013 | $450K |
| LLYELI LILLY & Co | 325 | $299K |
| JAZZJazz Pharmaceuticals plc | 1,554 | $294K |
| BMYBRISTOL MYERS SQUIBB CO | 4,731 | $287K |
| MRKMerck & Co., Inc. | 1,325 | $159K |
| REGNREGENERON PHARMACEUTICALS, INC. | 158 | $122K |
| MRNAModerna, Inc. | 1,231 | $63K |
| VTRSViatris Inc | 2,509 | $34K |
| CRSPCRISPR Therapeutics AG | 682 | $32K |
| VIRVir Biotechnology, Inc. | 2,195 | $20K |
| EDITEditas Medicine, Inc. | 1,250 | $3K |
| ALLOAllogene Therapeutics, Inc. | 740 | $2K |
| OGNOrganon & Co. | 41 | $246 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.